NASDAQ:SINT Sintx Technologies (SINT) Stock Price, News & Analysis → Protect Yourself While There’s Still Time … (From Weiss Ratings) (Ad) Free SINT Stock Alerts $0.04 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.04▼$0.0450-Day Range$0.02▼$0.1552-Week Range$0.02▼$1.82Volume24.15 million shsAverage Volume76.88 million shsMarket Capitalization$916,272.00P/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Sintx Technologies alerts: Email Address Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> About Sintx Technologies Stock (NASDAQ:SINT)Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.Read More SINT Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SINT Stock News HeadlinesApril 3, 2024 | msn.comWhy SINTX Technologies Stock Is Getting HammeredApril 3, 2024 | globenewswire.comSINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common StockApril 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.April 1, 2024 | msn.comWhy SINTX Technologies Stock Hit A New All-Time Low TodayMarch 29, 2024 | globenewswire.comSINTX Technologies Announces Proposed Public Offering of Common StockMarch 28, 2024 | investorplace.comSINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023March 25, 2024 | markets.businessinsider.comSintx Technologies Prices Public Offering Of $1.3 Mln Of SharesMarch 25, 2024 | msn.comWhy SINTX Technologies Stock Is Down 50%April 27, 2024 | Behind the Markets (Ad)Better than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.March 25, 2024 | investorplace.comWhy Is Sintx Technologies (SINT) Stock Down 31% Today?March 25, 2024 | globenewswire.comSINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common StockMarch 23, 2024 | msn.comUS Stocks Edge Lower; FedEx Posts Upbeat EarningsMarch 22, 2024 | msn.comGold Moves Lower; Lululemon Shares PlummetMarch 22, 2024 | markets.businessinsider.comDow Dips 200 Points; Nike Shares Fall After Q3 ResultsMarch 22, 2024 | markets.businessinsider.comSINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%March 22, 2024 | msn.comWhy SINTX Technologies Stock Is NosedivingMarch 22, 2024 | globenewswire.comSINTX Technologies Announces Proposed Public Offering of Common StockFebruary 24, 2024 | msn.comSintx Technologies (SINT) Price Target Increased by 42.86% to 10.20February 23, 2024 | benzinga.comTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)February 21, 2024 | finance.yahoo.comSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETFebruary 21, 2024 | globenewswire.comSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETFebruary 5, 2024 | realmoney.thestreet.comSintx Technologies just downgraded at Maxim, here's whyFebruary 3, 2024 | msn.comSintx Technologies Announces New Offering DetailsFebruary 2, 2024 | finance.yahoo.comSINTX Technologies Announces Closing of $4.0 Million Public OfferingFebruary 1, 2024 | msn.comSintx Technologies Partners with U.S. Army for 3D Printing AdvancementsFebruary 1, 2024 | markets.businessinsider.comSintx Tech Announces Pricing Public Offering; Stock DownJanuary 31, 2024 | msn.comWhat's Going On With SiNtx Technologies Stock?See More Headlines Receive SINT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sintx Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings3/27/2024Today4/26/2024Next Earnings (Estimated)5/20/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:SINT CUSIPN/A CIK1269026 Webwww.sintx.com Phone(855) 839-3500FaxN/AEmployees41Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.42) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-8,260,000.00 Net Margins-314.39% Pretax Margin-314.39% Return on Equity-67.12% Return on Assets-45.49% Debt Debt-to-Equity RatioN/A Current Ratio1.90 Quick Ratio1.60 Sales & Book Value Annual Sales$2.63 million Price / Sales0.35 Cash FlowN/A Price / Cash FlowN/A Book Value$1.65 per share Price / Book0.02Miscellaneous Outstanding Shares22,680,000Free Float22,453,000Market Cap$916,272.00 OptionableNot Optionable Beta1.46 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. B. Sonny Bal J.D. (Age 62)M.B.A., M.D., Ph.D., Chairman, President & CEO Comp: $460.81kMr. David Francis O'Brien (Age 58)Executive VP & COO Comp: $432.46kMr. Michael MarcroftVice President of Sales & MarketingMs. Gina MossDirector of OperationsKey CompetitorsMotus GINASDAQ:MOTSBluejay DiagnosticsNASDAQ:BJDXReShape LifesciencesNASDAQ:RSLSQuoin PharmaceuticalsNASDAQ:QNRXDynatronicsNASDAQ:DYNTView All Competitors SINT Stock Analysis - Frequently Asked Questions Should I buy or sell Sintx Technologies stock right now? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sintx Technologies in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SINT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SINT, but not buy additional shares or sell existing shares. View SINT analyst ratings or view top-rated stocks. How have SINT shares performed in 2024? Sintx Technologies' stock was trading at $0.3814 at the start of the year. Since then, SINT shares have decreased by 89.4% and is now trading at $0.0404. View the best growth stocks for 2024 here. Are investors shorting Sintx Technologies? Sintx Technologies saw a decrease in short interest in April. As of April 15th, there was short interest totaling 554,400 shares, a decrease of 54.6% from the March 31st total of 1,220,000 shares. Based on an average trading volume of 26,850,000 shares, the short-interest ratio is presently 0.0 days. View Sintx Technologies' Short Interest. When is Sintx Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 20th 2024. View our SINT earnings forecast. How were Sintx Technologies' earnings last quarter? Sintx Technologies, Inc. (NASDAQ:SINT) released its earnings results on Wednesday, March, 27th. The company reported ($0.09) EPS for the quarter. The firm earned $0.90 million during the quarter. Sintx Technologies had a negative net margin of 314.39% and a negative trailing twelve-month return on equity of 67.12%. When did Sintx Technologies' stock split? Shares of Sintx Technologies reverse split before market open on Monday, December 19th 2022. The 1-100 reverse split was announced on Monday, December 19th 2022. The number of shares owned by shareholders was adjusted after the market closes on Monday, December 19th 2022. An investor that had 100 shares of stock prior to the reverse split would have 1 shares after the split. What other stocks do shareholders of Sintx Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sintx Technologies investors own include Biocept (BIOC), Sorrento Therapeutics (SRNE), Heat Biologics (HTBX), iBio (IBIO), T2 Biosystems (TTOO), AIM ImmunoTech (AIM), Aytu BioPharma (AYTU), Blink Charging (BLNK), Bionano Genomics (BNGO) and Nuwellis (CHFS). How do I buy shares of Sintx Technologies? Shares of SINT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:SINT) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBiden out June 13; Kamala won’t replace him?Paradigm PressMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersA.I. is a Tidal Wave - Here’s What to BuyChaikin Analytics Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sintx Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
